Primary Central Nervous System Lymphoma
Also known as: Primary CNS Lymphoma (PCNSL) / Primary Lymphoma of the Central Nervous System / Primary Central Nervous System Lymphoma (PCNSL) / Primary CNS Lymphoma / Primary Central Nervous Lymphoma / PCNSL (Primary CNS Lymphoma) / PCNSL / Central nervous system lymphoma / Malignant lymphoma, no ICD-O subtype (morphologic abnormality) / Microglioma (disorder) / Microglioma -RETIRED- / [M]Microglioma (morphologic abnormality)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB01168 | Procarbazine | An antineoplastic agent indicated for the treatment of stage III and stage IV Hodgkin's disease in combination with other chemotherapeutic agents. |
| DB00853 | Temozolomide | An alkylating agent used to treat glioblastoma multiforme and refractory anaplastic astrocytoma. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB01168 | Procarbazine | DNA | target |
| DB01168 | Procarbazine | Xanthine dehydrogenase/oxidase | enzyme |
| DB01168 | Procarbazine | Monoamine oxidase | target |
| DB00853 | Temozolomide | DNA | target |
| DB00853 | Temozolomide | Serum albumin | carrier |
| DB00853 | Temozolomide | Alpha-1-acid glycoprotein 1 | carrier |
| DB00853 | Temozolomide | P-glycoprotein 1 | transporter |
| DB00853 | Temozolomide | ATP-binding cassette sub-family G member 2 | transporter |